Riverbend Wealth Management LLC Has $550,000 Stock Position in UnitedHealth Group Incorporated $UNH

Riverbend Wealth Management LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 31.6% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 1,761 shares of the healthcare conglomerate’s stock after selling 812 shares during the quarter. Riverbend Wealth Management LLC’s holdings in UnitedHealth Group were worth $550,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Nabity Jensen Investment Management Inc increased its stake in shares of UnitedHealth Group by 0.9% in the first quarter. Nabity Jensen Investment Management Inc now owns 2,760 shares of the healthcare conglomerate’s stock valued at $1,446,000 after buying an additional 24 shares in the last quarter. Atlantic Edge Private Wealth Management LLC raised its stake in shares of UnitedHealth Group by 8.9% in the first quarter. Atlantic Edge Private Wealth Management LLC now owns 305 shares of the healthcare conglomerate’s stock worth $160,000 after acquiring an additional 25 shares during the last quarter. Osborne Partners Capital Management LLC grew its stake in shares of UnitedHealth Group by 2.5% during the first quarter. Osborne Partners Capital Management LLC now owns 1,066 shares of the healthcare conglomerate’s stock valued at $558,000 after purchasing an additional 26 shares during the last quarter. HHM Wealth Advisors LLC increased its holdings in shares of UnitedHealth Group by 0.9% in the first quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock valued at $1,544,000 after purchasing an additional 26 shares in the last quarter. Finally, MPS Loria Financial Planners LLC lifted its holdings in UnitedHealth Group by 0.4% during the 1st quarter. MPS Loria Financial Planners LLC now owns 7,256 shares of the healthcare conglomerate’s stock worth $3,800,000 after buying an additional 27 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

UNH has been the topic of several research reports. JPMorgan Chase & Co. upped their price target on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $440.00 target price on shares of UnitedHealth Group in a research note on Tuesday, August 26th. Barclays increased their price objective on shares of UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a report on Thursday, October 9th. Baird R W downgraded UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Finally, Bank of America lifted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Seventeen investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company. According to MarketBeat.com, UnitedHealth Group has an average rating of “Hold” and a consensus price target of $384.09.

UnitedHealth Group Stock Performance

UNH stock opened at $355.73 on Friday. The firm has a market cap of $322.17 billion, a PE ratio of 15.41, a P/E/G ratio of 2.33 and a beta of 0.47. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The business’s 50-day moving average price is $327.27 and its two-hundred day moving average price is $346.01. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. During the same quarter last year, the firm earned $6.80 EPS. The company’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Investors of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. UnitedHealth Group’s dividend payout ratio is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.